medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2026, Number 2

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2026; 24 (2)

Herpes zoster. A study of 164 cases in primary care

Jarabo-García MT, García-Morán JI

Language: Spanish
References: 30
Page: 177-182
PDF size: 257.25 Kb.


ABSTRACT

BACKGROUND: Herpes zoster (HZ) results from the reactivation of latent varicella-zoster virus infection. While its pathophysiology is well-known, certain epidemiological aspects in primary care settings remain poorly characterized. This study aimed to assess the epidemiology, clinical features, and complications of a series of HZ cases in a primary care environment.
MATERIALS AND METHODS: An observational, descriptive study was conducted involving 164 cases of HZ diagnosed in a primary care setting.v RESULTS: The mean age of the patients was 68.56 years (SD: 13.64), with 73.80% of cases occurring in individuals over 65 years of age. The most frequent presenting symptoms were preherpetic neuralgia (96.34%), general malaise (18.29%), and fever (5.48%). Thoracic dermatomes were involved in more than 50% of cases. No significant association was found between the affected dermatome and age or sex. Postherpetic neuralgia was the most common complication and was significantly associated with advanced age. Incidence peaked during seasons with higher ultraviolet radiation (spring and summer).
CONCLUSIONS: The findings in our series are consistent with existing literature regarding sex distribution, presenting symptoms, affected dermatomes, and complications. However, we observed a higher mean age compared to other cohorts and a distinct seasonal predominance during spring and summer.


REFERENCES

  1. Zerboni L, Sen N, Oliver SL, Arvin AM. Molecular mechanismsof varicella zoster virus pathogenesis. Nat Rev Microbiol. 2014;12(3):197-210.

  2. Yawn BP, Gilden D. The global epidemiology of herpes zoster.Neurology. 2013;81(10):928-930.

  3. Muraki R, Iwasaki T, Sata T, Sato Y, et al. Hair follicle involvementin herpes zoster: pathway of viral spread from ganglia to skin.Virchows Arch. 1996;428(4-5):275-280.

  4. Weinberg JM. Herpes zoster: epidemiology, natural history,and common complications. J Am Acad Dermatol. 2007;57(6Suppl):S130-S135.

  5. Chidiac C, Jean Bruxelle J, Daures JP, Hoang-Xuan T, et al.Characteristics of patients with herpes zoster on presentationto practitioners in France. Clin Infect Dis. 2001;33(1):62-69.

  6. Van Oorschot D, Vroling H, Bunge E, Diaz-Decaro J, et al.A systematic literature review of herpes zoster incidenceworldwide. Hum Vaccin Immunother. 2021;17(6):1714-1732.

  7. Kawai K, Gebremeskel BG, Acosta CJ. Systematic review ofincidence and complications of herpes zoster: towards a globalperspective. BMJ Open. 2014;4(6):e004833.

  8. Thomas SL, Hall AJ. What does epidemiology tell us about riskfactors for herpes zoster? Lancet Infect Dis. 2004;4(1):26-33.

  9. Arvin A. Aging, immunity and varicella-zoster virus. N Engl JMed. 2005;352(22):2266-2267.

  10. Yawn BP, Saddier P, Wollan PC, St Sauver JL, et al. Apopulation-based study of the incidence and complication ratesof herpes zoster before zoster vaccine introduction. Mayo ClinProc. 2007;82(11):1341-1349.

  11. Laguna del Estal P. Complicaciones del herpes zóster.Emergencias. 2000;12:S19-S28.

  12. Foerster O. The dermatomes in man. Brain. 1933;56(1):1-39.

  13. Masa-Calles J, López-Perea N, Vila Cordero B, Carmona R.Vigilancia y epidemiología del herpes zóster en España. RevEsp Salud Pública. 2021;95:e1-e13.

  14. Buchan SA, Daneman N, Wang J, Wilson SE, et al. Herpes zosterin older adults in Ontario, 2002-2016: investigating incidenceand exploring equity. PLoS One. 2021;16(2):e0246086.

  15. Ragozzino MW, Melton LJ III, Kurland LT, Chu CP, et al.Population-based study of herpes zoster and its sequelae.Medicine (Baltimore). 1982;61(5):310-316.

  16. Hope-Simpson RE. The nature of herpes zoster: a long-termstudy and a new hypothesis. Proc R Soc Med. 1965;58(1):9-20.

  17. Glynn C, Crockford G, Gavaghan D, Cardno P, et al. Epidemiologyof shingles. J R Soc Med. 1990;83(10):617-619.

  18. Richards P. Shingles in one family practice. Arch Fam Med. 1996;5(1):42-46.

  19. Wilson JB. Thirty-one years of herpes zoster in a rural practice.BMJ. 1986;293(6558):1349-1351.

  20. Bordoli P, Bohn K, Pisani D. Variabilidad en los mapas dedermatomas: una revisión narrativa. Rev Arg Anat Online.2022;13(2):61-73.

  21. Nagasako EM, Johnson RW, Griffin DRJ, Dworkin RH. Rashseverity in herpes zoster: correlates and relationship topostherpetic neuralgia. J Am Acad Dermatol. 2002;46(6):834-839.

  22. Zografakis C, Tiniakos DG, Palaiologou M, Kouloukoussa M, etal. Increased density of cutaneous nerve fibres in the affecteddermatomes after herpes zoster therapy. Acta Derm Venereol.2014;94(2):168-172.

  23. Bollea-Garlatti ML, Bollea-Garlatti LA, Vacas AS, Torre AC, etal. Características clínicas y evolutivas de una población conherpes zoster diseminado: un estudio de cohorte retrospectiva.Actas Dermosifiliogr. 2017;108(2):145-152.

  24. Chen SY, Suaya JA, Li Q, Galindo CM, et al. Incidence of herpeszoster in patients with altered immune function. Infection.2014;42(2):325-334.

  25. Akiyama N. Herpes zoster infection complicated by motorparalysis. J Dermatol. 2000;27(4):252-257.

  26. Shiraki K, Toyama N, Shiraki A, Misako Y. Age-dependenttrigeminal and female-specific lumbosacral increase in herpeszoster distribution in the elderly. J Dermatol Sci. 2018;90(2):166-171.

  27. Goh CL, Khoo L. A retrospective study of the clinical presentationand outcome of herpes zoster in a tertiary dermatologyoutpatient referral clinic. Int J Dermatol. 1997;36(9):667-672.

  28. Vrcek I, Choudhury E, Durairaj V. Herpes zoster ophthalmicus: areview for the internist. Am J Med. 2017;130(1):21-26.

  29. Zaal MJW, Volker-Dieben HJ, D’Amaro J. Prognostic value ofHutchinson’s sign in acute herpes zoster ophthalmicus. GraefesArch Clin Exp Ophthalmol. 2003;241(3):187-191.

  30. Torres Ordóñez MG, Bastard D, Torre AC. Herpes zóster:actualización y manejo. Dermatol Argent. 2021;27(2):44-52.




2020     |     www.medigraphic.com